XVIII International AIDS Conference: 18-23 July 2010, Vienna
1 October 2010. Related: Conference reports.
World AIDS 18 Vienna 2010
Spray-dried nanoparticle formulation of efavirenz
1 October 2010. Related: Conference reports, Antiretrovirals.
Switching boosted-PIs to raltegravir
1 October 2010. Related: Conference reports, Antiretrovirals, Treatment strategies.
Scaling up: what to do first?
1 October 2010. Related: Conference reports, Treatment strategies, Guidelines.
A new point of care CD4 test
1 October 2010. Related: Conference reports, Basic science and immunology.
Early infant diagnosis
1 October 2010. Related: Conference reports, Antiretrovirals, Paediatric care, Diagnostics.
Efavirenz-based regimens among womenof reproductive age receiving ART in Johannesburg
1 October 2010. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Male circumcision retains effectiveness at reducing risk of HIV infection: 54 month results
1 October 2010. Related: Conference reports, HIV prevention and transmission.
AIDS 2010: non-technical conference summaries: HTB supplement
1 September 2010. Related: Special reports.
XVIII International AIDS Conference: 18-23 July 2010, Vienna
26 August 2010. Related: Conference reports.
Navigating the IAS Vienna conference online
26 August 2010. Related: Conference reports, On the web.
Results from the Caprisa 004 tenofovir microbicide trial
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Quadrivalent HPV vaccine reduces genital lesions and HPV acquisition in men
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Rilpivirine (TMC-278) vs efavirenz in treatment-naive patients: phase 3 results
26 August 2010. Related: Conference reports, Antiretrovirals.
Once-daily nevirapine extended release (XR) is non-inferior to current formulation
26 August 2010. Related: Conference reports, Antiretrovirals.
GSK572 (dolutegravir): second-generation integrase inhibitor
26 August 2010. Related: Conference reports, Antiretrovirals.
TBR-652: early results for CCR5 inhibitor
26 August 2010. Related: Conference reports, Antiretrovirals.
Atazanavir/r plus maraviroc or tenofovir/FTC in treatment-naive patients
26 August 2010. Related: Conference reports, Antiretrovirals.
Unboosted twice-daily atazanavir plus raltegravir
26 August 2010. Related: Conference reports, Antiretrovirals.
CASCADE analysis of when to start treatment
26 August 2010. Related: Conference reports, Antiretrovirals.
Impact of antiretroviral PMTCT prophylaxis regimens on subsequent maternal disease progression in Kesho Bora
26 August 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Birth outcomes with antiretroviral exposure
26 August 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
New WHO guidelines for children (July 2010)
26 August 2010. Related: Conference reports, Paediatric care, Guidelines.
No difference in outcomes for children initiating treatment with a protease inhibitor or an NNRTI nor with viral load switching strategies in PENPACT-1
26 August 2010. Related: Conference reports, Antiretrovirals, Paediatric care.
Tablets more acceptable than syrups in the ARROW trial
26 August 2010. Related: Conference reports, Antiretrovirals, Treatment strategies, Paediatric care.
Smoking and atazanavir levels
26 August 2010. Related: Conference reports, PK and drug interactions.
Darunavir/ritonavir and rosuvastatin
26 August 2010. Related: Conference reports, PK and drug interactions.
Lime juice is not a microbicide: do not try at home
26 August 2010. Related: Conference reports, Women's health, HIV prevention and transmission.